$69.66 -0.28 (%) Mylan N.V. - NASDAQ

May. 22, 2015 | 04:00 PM

Partner Headlines

  1. Endo International Acquires Par Pharmaceuticals For $8 Billion

    GuruFocus | May. 21, 2015 | 10:48AM EST
  2. Endo Buying Generics Maker

    IBD | May. 18, 2015 | 18:54PM EST
  3. Tom Russo Buys 3 New Stocks in Q1

    GuruFocus | May. 18, 2015 | 14:51PM EST
  4. Endo Buying Par Pharma To Become Top Generics Player

    IBD | May. 18, 2015 | 10:38AM EST
  5. U.S. Loves Europe As Pharma, Energy Boost M&A

    IBD | May. 14, 2015 | 17:45PM EST
  6. Actavis Offers Post-Allergan Guidance; Ligand Jumps

    IBD | May. 11, 2015 | 18:36PM EST
  7. Actavis Q1 Beats Estimates, Includes Allergan In 2015 Guidance

    IBD | May. 11, 2015 | 10:59AM EST
  8. Benzinga's Weekend M&A Chatter

    Benzinga | May. 10, 2015 | 20:50PM EST
  9. ObamaCare, Generic Drugs Boost AmerisourceBergen

    IBD | May. 8, 2015 | 18:59PM EST
  10. Making Money With Charles Payne: 05/8/15

    FoxBusiness | May. 8, 2015 | 18:00PM EST
  11. Report: Mylan Might See Higher Bid From Teva

    Benzinga | May. 8, 2015 | 14:20PM EST
  12. Jim Chanos, Kyle Bass Rip Oil And Pharma At SALT 2015

    Benzinga | May. 7, 2015 | 17:39PM EST
  13. Mylan Q1 Mixed; Abiomed, Mallinckrodt, Zoetis Beat

    IBD | May. 5, 2015 | 18:59PM EST
  14. Health Issues Top, Mostly

    IBD | May. 5, 2015 | 18:31PM EST
  15. Top Stock Mutual Fund New Buys: CyberArk Software

    IBD | May. 5, 2015 | 18:28PM EST
  16. Report Sees 'Cognitive Dissonance' In Mylan's Internal Price Target

    Benzinga | May. 4, 2015 | 16:30PM EST
  17. Mylan Launches Gilead Sciences' Sovaldi Tablets in India

    Benzinga | May. 4, 2015 | 05:31AM EST
  18. M&A Fever Grips Drugmakers

    IBD | May. 1, 2015 | 18:44PM EST
  19. Is The Drug Industry's Wedding Dance Nearly Finished?

    IBD | May. 1, 2015 | 16:08PM EST
  20. Teva tops as it tries for Mylan

    IBD | Apr. 30, 2015 | 18:43PM EST
  21. Teva, Celgene, Novo Nordisk, Shire Report Q1 Earnings

    IBD | Apr. 30, 2015 | 10:48AM EST
  22. Benzinga's M&A Chatter for Wednesday April 29, 2015

    Benzinga | Apr. 29, 2015 | 20:01PM EST
  23. Perrigo rejects new Mylan bid

    IBD | Apr. 29, 2015 | 18:38PM EST
  24. Mylan Raises Perrigo Bid, But Perrigo Still Says No

    IBD | Apr. 29, 2015 | 12:28PM EST
  25. Benzinga's M&A Chatter for Monday April 27, 2015

    Benzinga | Apr. 27, 2015 | 22:58PM EST
  26. Mylan Rejects 'Low Quality'

    IBD | Apr. 27, 2015 | 18:56PM EST
  27. Nasdaq Leads Market Lower As Medical Stocks Tumble

    IBD | Apr. 27, 2015 | 16:16PM EST
  28. 4 Drug Giants Reporting Earnings This Week

    IBD | Apr. 27, 2015 | 13:33PM EST
  29. Mylan Rejects Teva Bid After Raising Bid For Perrigo

    IBD | Apr. 27, 2015 | 12:45PM EST
  30. Stocks Poised For Higher Start; Applied Materials Slides

    IBD | Apr. 27, 2015 | 09:02AM EST
  31. Teva Puts Forth Its Best Bid To Acquire Mylan

    GuruFocus | Apr. 25, 2015 | 19:34PM EST
  32. Perrigo rebuffs Mylan again

    IBD | Apr. 24, 2015 | 19:12PM EST
  33. Mylan 'Raises' Perrigo Bid, But Teva Buzz Builds

    IBD | Apr. 24, 2015 | 17:51PM EST
  34. Worst Performing Industries For April 24, 2015

    Benzinga | Apr. 24, 2015 | 11:16AM EST
  35. CalAmp and Illumina Significant Earnings Growth; Perrigo Rebuffs Takeover Offer

    GuruFocus | Apr. 22, 2015 | 11:28AM EST
  36. Teva Files for Hart-Scott-Rodino Notification Regarding Proposed Acquisition of Mylan

    Benzinga | Apr. 22, 2015 | 08:33AM EST
  37. Benzinga's M&A Chatter for Tuesday April 21, 2015

    Benzinga | Apr. 21, 2015 | 19:37PM EST
  38. Teva Offers $40 Bil For Mylan; Perrigo Rejects Mylan

    IBD | Apr. 21, 2015 | 19:04PM EST
  39. Teva Offers, Perrigo Rejects

    IBD | Apr. 21, 2015 | 18:51PM EST
  40. Stocks End Mixed As Technology Sector Leads

    IBD | Apr. 21, 2015 | 16:34PM EST
  41. Buyers Prop Up Nasdaq; Chipotle Rises Ahead Of Earnings

    IBD | Apr. 21, 2015 | 14:49PM EST
  42. Stocks Mixed, But Palo Alto Hits High On Analyst Nod

    IBD | Apr. 21, 2015 | 12:07PM EST
  43. Teva Bids $40 Billion For Mylan, But May Need More

    IBD | Apr. 21, 2015 | 11:35AM EST
  44. Benzinga's Volume Movers

    Benzinga | Apr. 21, 2015 | 11:29AM EST
  45. Mylan Shares Jump On $40 Billion Bid From Teva Pharmaceutical

    Benzinga | Apr. 21, 2015 | 10:52AM EST
  46. Stocks Slip Into Mixed Trade; DuPont, Harley-Davidson Dive

    IBD | Apr. 21, 2015 | 10:35AM EST
  47. Teva Offers $82 A Share For Mylan; Stocks Rise

    IBD | Apr. 21, 2015 | 09:17AM EST
  48. Stock Futures Mildly Positive; Mylan, Fortinet, Mellanox Surge

    IBD | Apr. 21, 2015 | 09:01AM EST
  49. Benzinga's Top #PreMarket Losers

    Benzinga | Apr. 21, 2015 | 08:23AM EST
  50. Benzinga's Weekend M&A Chatter

    Benzinga | Apr. 19, 2015 | 19:10PM EST
Trading Center